| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Accounting Officer | Principal Accounting Officer
2 companies
Richard J Napolitano last filed a Form 4 in March 2024, as Chief Accounting Officer at TDOC. The filings on record cover 2 companies. Richard J Napolitano's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Richard J Napolitano's trades have earned a strong insider score of 85/100 across 10 rated trades. Over a 12-month horizon, all 10 of those trades were profitable, with an average 12-month return of +47.3%.
At the last filing, the largest reported position was 6,963 shares of MSCI. The MSCI filings lean toward selling, a net 7,115 shares.
Richard J Napolitano has 37 Form 4 filings on record from January 2015 to March 2024, across 2 companies: Chief Accounting Officer at Teladoc Health (TDOC), 2021–2024; Principal Accounting Officer at Msci (MSCI), 2015–2018.
The 68 reported transactions were 23 option exercises, 15 tax withholdings, 12 open-market sales and 11 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 12 sales worth about $1.1M.
The largest open-market sale was 3,362 shares of MSCI at an average $154.75 on May 7, 2018, about $520K.
None of the 6 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 3,765 | $14.52 | $54,652.74 | -17.2% | -24.8% | -37.5% | |
| Feb 2, 2024 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 872 | $19.18 | $16,723.22 | -6.9% | -34.4% | -48.7% | |
| Dec 4, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 652 | $18.90 | $12,324.10 | -5.8% | -22.6% | -42.5% | |
| Sep 25, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 219 | $18.68 | $4,090.70 | -2.3% | +14.6% | -53.7% | |
| Sep 5, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 649 | $22.89 | $14,858.21 | -6.7% | -16.9% | -67.5% | |
| Jun 2, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 1,579 | $24.38 | $38,497.60 | -16.6% | -7.5% | -54.1% | |
| Mar 2, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 1,384 | $25.36 | $35,101.01 | -21.6% | -9.0% | -41.0% | |
| Feb 2, 2023 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 787 | $33.00 | $25,973.36 | -21.9% | -22.5% | -40.4% | |
| Sep 23, 2022 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 220 | $27.65 | $6,083.88 | -12.2% | -10.2% | -30.4% | |
| Feb 2, 2022 | TDOC Teladoc Health, Inc. | Chief Accounting Officer | Sale+OE | 824 | $78.66 | $64,813.37 | -40.8% | -50.2% | -56.8% |